Liyuan Wang

Title: Liyuan Wang: Innovator in Heterocyclic Compounds

Introduction

Liyuan Wang is a prominent inventor based in Warren, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel heterocyclic compounds. Her work focuses on creating innovative solutions for thromboembolic disorders.

Latest Patents

Liyuan Wang holds a patent for "Heterocyclic compounds as factor IXA inhibitors." This invention relates to novel heterocyclic compounds of Formulae I-III, as disclosed in her patent. It also includes pharmaceutically acceptable salts, solvates, esters, prodrugs, or stereoisomers thereof. The patent further details pharmaceutical compositions comprising these compounds and methods for using them to treat or prevent thromboembolic disorders. She has 1 patent to her name.

Career Highlights

Liyuan Wang is currently employed at Schering Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in the pharmaceutical industry, contributing to the creation of effective treatments for serious medical conditions.

Collaborations

Throughout her career, Liyuan has collaborated with notable colleagues, including Martin C Clasby and William J Greenlee. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Liyuan Wang is a dedicated inventor whose work in heterocyclic compounds has the potential to significantly improve treatment options for thromboembolic disorders. Her contributions to the pharmaceutical field exemplify the importance of innovation in healthcare.